TY  - JOUR 
AU  - Quindós Varela, María
PY  - 2015
SN  - 0959-8049
UR  - http://hdl.handle.net/20.500.11940/3625
LA  - eng
TI  - GEINO-11: A prospective multicenter, open label, phase II pilot clinical trial to evaluate safety and efficacy of Dacomitinib, a pan-HER irreversible inhibitor, in patients with recurrent glioblastoma with EGFR amplification or presence of EGFRvIII mutati
T2  - EUROPEAN JOURNAL OF CANCER
M2  - S585
VL  - 51
ER  -